255 related articles for article (PubMed ID: 33061335)
1. Severe Aortic Stenosis and ATTRwt Amyloidosis - Beware in the Aging: A Case Report and Review of the Literature.
Adam R; Munteanu A; Mititelu R; Onciul S; Deleanu D; Iliescu VA; Popescu BA; Jurcut R
Clin Interv Aging; 2020; 15():1863-1872. PubMed ID: 33061335
[TBL] [Abstract][Full Text] [Related]
2. [Wild-type transthyretin-related cardiac amyloidosis and degenerative aortic stenosis: Two inter-related pathologies in the elderly].
Calero Núñez S; Tercero Martínez A; García López JC; Jiménez-Mazuecos J
Rev Esp Geriatr Gerontol; 2017; 52(3):167-170. PubMed ID: 27292540
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac Amyloidosis.
Annabi MS; Carter-Storch R; Zaroui A; Galat A; Oghina S; Kharoubi M; Bezard M; Derumeaux G; Fanen P; Lemonnier F; Poullot E; Itti E; Gallet R; Teiger E; Pibarot P; Damy T; Clavel MA
J Am Heart Assoc; 2024 Jul; 13(13):e034723. PubMed ID: 38904242
[TBL] [Abstract][Full Text] [Related]
4. Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study.
Singal AK; Bansal R; Singh A; Dorbala S; Sharma G; Gupta K; Saxena A; Bhargava B; Karthikeyan G; Ramakrishnan S; Bisoi AK; Hote MP; Rajashekar P; Chowdhury UK; Devagourou V; Patel C; Ray R; Arawa SK; Mishra S
JACC CardioOncol; 2021 Oct; 3(4):565-576. PubMed ID: 34746852
[TBL] [Abstract][Full Text] [Related]
5. In the midst of a dangerous intersection with unclear therapeutic strategies: a challenging case of severe aortic stenosis.
Gallone G; Landra F; D'Ascenzo F; Conrotto F; Casoni R; Bruno F; Omedè P; Alunni G; Andreis A; Vairo A; Giorgi M; Fava A; De Ferrari GM
BMC Cardiovasc Disord; 2020 Jun; 20(1):261. PubMed ID: 32487051
[TBL] [Abstract][Full Text] [Related]
6. Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis.
Rosenblum H; Masri A; Narotsky DL; Goldsmith J; Hamid N; Hahn RT; Kodali S; Vahl T; Nazif T; Khalique OK; Bokhari S; Soman P; Cavalcante JL; Maurer MS; Castaño A
Eur J Heart Fail; 2021 Feb; 23(2):250-258. PubMed ID: 32729170
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of moderate-severe aortic stenosis in patients with cardiac amyloidosis in a referral center.
Decotto S; Corna G; Villanueva E; Arenaza DP; Seropian I; Falconi M; Oberti P; Aguirre MA; Posadas-Martínez ML; Carretero M; Agatiello CR; Pizarro R
Arch Cardiol Mex; 2024; 94(1):71-78. PubMed ID: 38507302
[TBL] [Abstract][Full Text] [Related]
8. Value of Longitudinal Strain to Identify Wild-Type Transthyretin Amyloidosis in Patients With Aortic Stenosis.
Robin G; Cognet T; Bouisset F; Cariou E; Méjean S; Pradel S; Colombat M; Galinier M; Carrié D; Lairez O;
Circ J; 2021 Aug; 85(9):1494-1504. PubMed ID: 33980765
[TBL] [Abstract][Full Text] [Related]
9. Transthyretin cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: experience of a single center.
Gallone G; Bongiovanni C; Bruno F; Landra F; Andreis A; Fava A; Scudeler L; DE Filippo O; Califaretti E; Cioffi M; Pidello S; Vairo A; Raineri C; Frea S; Giorgi M; Alunni G; Casoni R; Salizzoni S; Conrotto F; D'Ascenzo F; Rinaldi M; DE Ferrari GM
Minerva Cardiol Angiol; 2024 Feb; 72(1):87-94. PubMed ID: 37405712
[TBL] [Abstract][Full Text] [Related]
10. Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week.
Ternacle J; Krapf L; Mohty D; Magne J; Nguyen A; Galat A; Gallet R; Teiger E; Côté N; Clavel MA; Tournoux F; Pibarot P; Damy T
J Am Coll Cardiol; 2019 Nov; 74(21):2638-2651. PubMed ID: 31753206
[TBL] [Abstract][Full Text] [Related]
11. Transthyretin Cardiac Amyloidosis and Aortic Stenosis: Connection and Therapeutic Implications.
Penalver J; Ambrosino M; Jeon HD; Agrawal A; Kanjanahattakij N; Pitteloud M; Stempel J; Amanullah A
Curr Cardiol Rev; 2020; 16(3):221-230. PubMed ID: 31544701
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of ATTR-CA and high-risk features to guide testing in patients referred for TAVR.
Abadie B; Ali AH; Martyn T; Higgins A; Krishnaswamy A; Reed G; Puri R; Yun J; Cremer P; Hanna M; Tang WHW; Kapadia S; Jaber W
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3910-3916. PubMed ID: 37606857
[TBL] [Abstract][Full Text] [Related]
13. Quantification of Myocardial Extracellular Volume With Planning Computed Tomography for Transcatheter Aortic Valve Replacement to Identify Occult Cardiac Amyloidosis in Patients With Severe Aortic Stenosis.
Oda S; Kidoh M; Takashio S; Inoue T; Nagayama Y; Nakaura T; Shiraishi S; Tabata N; Usuku H; Kaikita K; Tsujita K; Ikeda O
Circ Cardiovasc Imaging; 2020 May; 13(5):e010358. PubMed ID: 32370615
[No Abstract] [Full Text] [Related]
14. Wild-Type Transthyretin Cardiac Amyloidosis is Not Rare in Elderly Subjects: the CATCH Screening Study.
Aimo A; Vergaro G; Castiglione V; Fabiani I; Barison A; Gentile F; Ferrari Chen YF; Giorgetti A; Genovesi D; Buda G; Franzini M; Piepoli M; Moscardini S; Rapezzi C; Fontana M; Passino C; Emdin M
Eur J Prev Cardiol; 2024 Mar; ():. PubMed ID: 38456769
[TBL] [Abstract][Full Text] [Related]
15. Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis.
Herrmann HC; Pibarot P; Hueter I; Gertz ZM; Stewart WJ; Kapadia S; Tuzcu EM; Babaliaros V; Thourani V; Szeto WY; Bavaria JE; Kodali S; Hahn RT; Williams M; Miller DC; Douglas PS; Leon MB
Circulation; 2013 Jun; 127(23):2316-26. PubMed ID: 23661722
[TBL] [Abstract][Full Text] [Related]
16. Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?
Galat A; Guellich A; Bodez D; Slama M; Dijos M; Zeitoun DM; Milleron O; Attias D; Dubois-Randé JL; Mohty D; Audureau E; Teiger E; Rosso J; Monin JL; Damy T
Eur Heart J; 2016 Dec; 37(47):3525-3531. PubMed ID: 26908951
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Occult Transthyretin Cardiac Amyloidosis in Patients With Severe Aortic Stenosis Undergoing Surgical Aortic Valve Replacement: An Unrecognized Disease Modifier.
Koyama J
Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27511980
[No Abstract] [Full Text] [Related]
18. [Cardiac amyloidosis and aortic stenosis: what do we know?].
Sena G; Ruotolo I; Zaccaro A; Ponziani A; Saturi G; Gagliardi C; Biagini E; Longhi S
G Ital Cardiol (Rome); 2024 Jul; 25(7):483-490. PubMed ID: 38916463
[TBL] [Abstract][Full Text] [Related]
19. ATTR Amyloidosis: Current and Emerging Management Strategies:
Griffin JM; Rosenthal JL; Grodin JL; Maurer MS; Grogan M; Cheng RK
JACC CardioOncol; 2021 Oct; 3(4):488-505. PubMed ID: 34729521
[TBL] [Abstract][Full Text] [Related]
20. Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications.
Balciunaite G; Rimkus A; Zurauskas E; Zaremba T; Palionis D; Valeviciene N; Aidietis A; Serpytis P; Rucinskas K; Sogaard P; Glaveckaite S; Zorinas A; Janusauskas V
Hellenic J Cardiol; 2020; 61(2):92-98. PubMed ID: 31740363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
